Why You May Want a Second Opinion About Advanced Renal Cell Carcinoma Treatments

Diagnosed With Advanced Renal Cell Carcinoma: Why You May Want a Second Opinion, and How to Find One

Diagnosed With Advanced Renal Cell Carcinoma: Why You May Want a Second Opinion, and How to Find One
Adobe Stock

Many people with cancer can benefit from a second medical opinion. Those with advanced renal cell carcinoma (RCC), who are likely considering multiple treatment options, if not combinations of treatment options, can find it especially helpful to hear another oncologist’s thoughts.

“Renal cell carcinoma has so much variability in the ways it can be treated,” says Jacqueline T. Brown, MD, a medical oncologist with Emory Healthcare and an assistant professor at the Winship Cancer Institute at Emory University in Atlanta. “There are often multiple right answers depending on the individual patient’s situation.”

Here are a few reasons you may want to consider talking to a second provider.

Why You Should Seek a Second Opinion

Seeking out a second opinion can give you the confidence that you’re getting the best treatment available — something that can be especially important for people who have fewer resources for cancer care.

Some Groups Have Discrepancies in Care

There’s some evidence that racial or socioeconomic factors play a role in treatment decisions and outcomes. Black patients, for example, tend to have lower survival rates than non-Hispanic white patients, with some research showing that Black patients are offered less aggressive surgical or medical treatments for RCC.

 Other research suggests that socioeconomic factors like income, insurance status, and access to care play a role in the discrepancy.

There May Be More Than One Right Treatment

Since renal cell carcinoma can be treated in a variety of ways, it may be worth seeing if you prefer one doctor’s recommendations over another. “Different providers may have alternate approaches in treating the same disease,” says Farshid Sadeghi, MD, a urologic oncology surgeon and the chief of surgery at City of Hope Cancer Center in Phoenix, Arizona.

Treatments for advanced RCC include the following options:

  • Immunotherapy This includes monoclonal antibodies and immune checkpoint inhibitors such as pembrolizumab (Keytruda).
  • Targeted Therapies Therapies like tyrosine kinase inhibitors (TKIs) are designed to target specific proteins that help cancer grow.
  • Surgery These procedures remove the affected kidney.
  • External Beam Radiotherapy This is a type of radiation treatment.
  • Chemotherapy Medication given through an IV eliminates cancer cells.
You can also ask your healthcare provider whether any clinical trials are available at your local treatment center or other centers around the country.

There Are Newer Treatment Options Available

“The treatment landscape of ‌advanced RCC has dramatically changed in the past decade,” says Anthony Gulati, MD, a hematologist-oncologist with Stamford Health in Connecticut. While TKI medications have been the standard of care for renal cell carcinoma, the landscape has evolved with the development of newer TKI agents and also immunotherapies, says Dr. Gulati.

Current guidelines recommend combination treatments like a TKI plus immunotherapy or two types of immunotherapy.

The nuance of which treatment combination to use in which scenario depends on your symptoms, cancer stage, and biomarkers — tiny biological clues found in blood or tissue tests, says Gulati.

There Are Advanced Surgical Techniques Available

Surgical options for advanced RCC include total or partial kidney removal (nephrectomy).

 Your surgeon may do this by making larger incisions to see your kidney more clearly (open surgery) or smaller incisions while using cameras and tiny tools (robotic surgery), says Dr. Sadeghi.

It’s important to take into consideration how much experience a surgeon has with this procedure, as well as the reasons why they’re advocating for the surgery, says Sadeghi.

When to Seek a Second Opinion

It’s never too late or too early to ask for a second opinion, but Dr. Brown says that two good times to do so are when you’re first diagnosed and when your provider recommends a switch in treatment.

Some red flags may prompt seeking a second opinion:

  • You don’t feel confident in your doctor’s diagnosis.
  • Multiple treatments haven’t worked.
  • You have an unusual type of renal carcinoma.
  • Your provider is unwilling to try other options.
  • You feel uncomfortable with your doctor or are unable to ask them questions.
  • Your provider makes decisions about your treatment plan without consulting you.

“I also advise patients to just trust their gut,” says Brown. “If at any point in your treatment course you feel like you want a second opinion, then that’s the right time to get one.”

“As an oncologist,” says Brown, “I have confidence in the recommendations I make for patients, but if they are interested in a second opinion, it only helps me.” Sometimes patients return to her clinic even more confident in her treatment recommendation, or they find clinical trials somewhere else that fit them better.

You may feel nervous to hold off on treatment until you get a second opinion — and sometimes treatment does need to start right away — but in most cases, you have time to see another provider and think over your options.

How to Find a Doctor for a Second Opinion

You can find a doctor to provide a second opinion through your current provider, your health insurance company, and support organizations.

 Before you start looking, check with your health insurance plan to make sure they will cover a second opinion, so you don’t have any surprise bills afterward.

If you need help finding another provider, you can try these tactics:

  • Ask your current doctor for their recommendation.
  • Speak with a social worker.
  • Join a renal cell carcinoma support group to get recommendations from others with this cancer.

Questions to Ask

Before your appointment, write down every question you can think of to ask the new doctor. Our experts recommend asking these questions at your second opinion visit:

  • What do you think of my treatment up to this point and the future plan?
  • Can you explain what treatment options are available to me?
  • What is your experience with these options?
  • How does my treatment plan compare to those recommended by national guidelines?
  • If I need surgery, what can I expect before and after?
  • What is your surgical experience?
  • Do you know of any clinical trials that might be a good fit for me?
  • Do these clinical trials require travel?

What to Do After a Second Opinion

After you get a recommendation from your second opinion physician, you can decide if you’d like to move forward with them or go back to your original provider. If the two offered different treatment options, you can ask both doctors these questions:

  • What do you think of the other provider’s treatment plan?
  • Which research studies or national guidelines do you follow to make recommendations?
  • Why would you choose your own plan over the other?
You can also ask the two doctors for a joint meeting or an online conference with a group of providers that could include surgeons, medical oncologists, and more, who then all agree on a plan together, says Gulati.

The Takeaway

  • It may be a good idea to seek out a second opinion regarding advanced renal cell carcinoma treatment, especially if you lack access to some cancer care resources.
  • There’s not necessarily a best treatment for advanced RCC — rather, multiple treatment options can be equally effective.
  • If you want to seek out a second opinion, try asking your current provider for a referral. You can also ask a social worker, a support group peer, or your health insurer.
  • If your second opinion matches your first, you can move forward with confidence; if they don’t match, you can ask both providers to meet and agree on a plan.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Meagher MF et al. Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC). Urology. May 2022.
  2. Chow RD et al. Disparities in Immune and Targeted Therapy Utilization for Older US Patients With Metastatic Renal Cell Carcinoma. JNCI Cancer Spectrum. May 18, 2023.
  3. Alam R et al. Socioeconomic Determinants of Racial Disparities in Survival Outcomes Among Patients With Renal Cell Carcinoma. Urologic Oncoloy: Seminars and Original Investigations. November 2023.
  4. Renal Cell Cancer Treatment (PDQ)–Health Professional Version. National Cancer Institute. May 13, 2025.
  5. Getting a Second Opinion. Kidney Cancer Association. January 2026.
  6. Renal Cell Cancer Treatment (PDQ)–Patient Version. National Cancer Institute. May 12, 2025.
  7. Getting a Second Doctor’s Opinion. American Kidney Fund.
  8. Seeking a Second Opinion. American Cancer Society. July 31, 2025.

Daniel Landau, MD

Medical Reviewer

Daniel Landau, MD, is a distinguished board-certified hematologist-oncologist with a career that has spanned two eminent institutions: the Orlando Health Cancer Institute and the Medical University of South Carolina. With a specialized interest in genitourinary oncology and hematology, he has been at the forefront of managing both benign and malignant conditions.

Dr. Landau is a pioneering figure in integrating advanced technology into oncology, having served as a director of telemedicine services. Under his leadership, multiple innovative systems have been designed and piloted, all with a singular focus: enhancing the patient experience.

Beyond his clinical and technological endeavors, Landau is deeply committed to medical education. He has dedicated significant time and expertise to nurturing the skills of medical students, residents, and fellows, ensuring that the flame of knowledge and compassion burns bright in the next generation of oncologists.

Abby McCoy, RN

Author

Abby McCoy is an experienced registered nurse who has worked with adults and pediatric patients encompassing trauma, orthopedics, home care, transplant, and case management. She is a married mother of four and loves the circus — that is her home! She has family all over the world, and loves to travel as much as possible.

McCoy has written for publications like Remedy Health Media, Sleepopolis, and Expectful. She is passionate about health education and loves using her experience and knowledge in her writing.